IMMUNIC INC (IMUX)
US4525EP1011 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to IMUX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.73. This target is 830.95% above the current price.
IMUX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about IMUX.
In the previous month the buy percentage consensus was at a similar level.
IMUX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-05 | Brookline Capital | Initiate | Buy |
| 2023-10-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-07-27 | Wedbush | Reiterate | Outperform -> Outperform |
| 2022-10-21 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-08 | Aegis Capital | Maintains | Buy |
| 2022-06-03 | SVB Leerink | Maintains | Outperform |
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2021-09-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-15 | Aegis Capital | Initiate | Buy |
| 2021-03-24 | JMP Securities | Initiate | Market Outperform |